Skip to main content
Premium Trial:

Request an Annual Quote

GE Unit to Offer After-Market Services for Ciphergen

NEW YORK, Dec. 18 (GenomeWeb News) - A unit of General Electric will become Ciphergen Biosystems' post-sale services partner for its ProteinChip systems for hospitals in China, Hong Kong, and Taiwan, the companies said today.

 

Ciphergen and GE Medical Systems have been working together in Chinaon an "informal basis" for the past year, and have now established a "formal," multi-year services agreement. The agreement is with the Medical Systems' Trade and Development unit.

Financial and other terms of the agreement were not disclosed.

"GE Medical Systems has a major presence ... in China," William Rich, president and CEO of Ciphergen, said in a statement. "Chinais investing heavily in leading edge biotechnology research and we hope to jointly play a significant role in fostering the adoption of our ProteinChip products as research and diagnostic platforms in this important market."

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.